Industry Advisory Group

The Industry Advisory Group supports the IGPRG and is comprised of key industry representatives. This enables effective ongoing cross-jurisdictional and cross-agency collaboration on design, delivery and implementation of national reforms to the health and medical research operating environment.

Role

The role of the Industry Advisory Group (IAG) is to provide advice to IGPRG on national health reform initiatives including the National One Stop Shop, specifically in relation to:

  • sector and industry perspectives as requested
  • sector and industry issues as relevant. 

The IAG works to further the IGPRG role and objectives, initiatives and underpinning principles. IAG is an agile and responsive group to identify opportunities for improving the operating environment, and test key policy and reform ideas.

Member

RepresentativeOrganisation 
Dr Julie White (Chair)IGPRG member
Laurena McNeillDepartment of Industry, Science and Resources
Adjunct Professor Tim Boyle ARCS Australia
Rebekah CassidyAusBiotech
Professor Michael Boyer AMAustralian Private Hospitals Association
Kylie SprostonBellberry Limited
James McAdamBristol Myers Squibb
Katharine Bassett Catholic Health Australia
Sophie StokesDay Hospitals Australia
Elizabeth de Somer Medicines Australia
Stuart Dignam MTPConnect
Ian BurgessMedical Technology Association of Australia
Professor John SimesAustralian New Zealand Clinical Trials Registry
Carrie BloomfieldResearch & Development Taskforce
David LloydResearch & Development Taskforce

Meetings

IAG aims to meet 4 times a year.  Additional meetings may be held if needed.

Communiques

  1. Industry Advisory Group Meeting 01 – Communique
  2. Industry Advisory Group Meeting 02 – Communique
  3. Industry Advisory Group Meeting 03 – Communique

Related committees of groups

Contact

Contact us for more information about IGPRG and sub-committees.

Date last updated:
Tags:
  • About clinical trials